{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T11:51:46Z","timestamp":1788954706535,"version":"build-2803163510"},"reference-count":34,"publisher":"SAGE Publications","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Medicine"],"published-print":{"date-parts":[[2022,1]]},"abstract":"<jats:p>The clinical spectrum of autoimmune gastritis is silent in the early stages of the disease and no specific symptom is related to this entity. Although gastroscopic findings of this entity are well defined, data regarding colonoscopic findings are limited. The aims of this study were to determine the prevalence of colonoscopic findings and to explore factors that might affect these findings. This is a retrospective chart review of patients with autoimmune gastritis (n=240). Data regarding colonoscopic findings, serum gastrin and chromogranin A (CgA) levels and gastric histopathological results were extracted and compared with 550 patients positive for Helicobacter pylori and gastric atrophy. Control subjects had colonoscopy and gastroscopy with biopsies. Colorectal lesions were observed in 64 (26.6%) of patients with autoimmune gastritis and 36 (6.6%) patients had colorectal lesions in the control group (p&lt;0.001). Serum gastrin (OR: 8.59, 95% CI 1.72 to 25.07, p&lt;0.001) and CgA levels (OR: 6.79, 95% CI 0.41 to 27.26, p&lt;0.001) were found as factors affecting the presence of colorectal carcinoma. Serum gastrin and CgA levels were also found as predictors for the presence of colorectal adenomas. There is a higher prevalence of colorectal neoplastic lesions in patients with autoimmune gastritis. Serum gastrin and CgA levels were found to be determinants of colorectal neoplastic lesions observed in patients. In the workup of these patients, serum gastrin and CgA levels may guide physicians for the demonstration of colorectal neoplastic lesions.<\/jats:p>","DOI":"10.1136\/jim-2021-001911","type":"journal-article","created":{"date-parts":[[2021,8,2]],"date-time":"2021-08-02T12:16:23Z","timestamp":1627906583000},"page":"73-78","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":1,"title":["Prevalence and Predictors of Colonoscopic Findings in Patients with Autoimmune Gastritis"],"prefix":"10.1177","volume":"70","author":[{"given":"Emra","family":"Asfuroglu Kalkan","sequence":"first","affiliation":[{"name":"Departments of Internal Medicine and Gastroenterology, Ministry of Health, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cagdas","family":"Kalkan","sequence":"additional","affiliation":[{"name":"Gastroenterology, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesut","family":"Gumussoy","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Ibni Sina Hospital, Ankara University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozge","family":"Gucbey","sequence":"additional","affiliation":[{"name":"Departments of Internal Medicine and Gastroenterology, Ministry of Health, Ankara City Hospital, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5971-4361","authenticated-orcid":false,"given":"Irfan","family":"Soykan","sequence":"additional","affiliation":[{"name":"Division of Gastroenterology, Ibni Sina Hospital, Ankara University Faculty of Medicine, Ankara, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,5,25]]},"reference":[{"key":"bibr1-jim-2021-001911","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2013.101"},{"key":"bibr2-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Lenti MV, Miceli E, Cococcia S, Determinants of diagnostic delay in autoimmune atrophic gastritis. Aliment Pharmacol Ther 2019;50:167\u201375.doi:10.1111\/apt.15317http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31115910","DOI":"10.1111\/apt.15317"},{"key":"bibr3-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Soykan I, Yakut M, Keskin O, Clinical profiles, endoscopic and laboratory features and associated factors in patients with autoimmune gastritis. Digestion 2012;86:20\u20136.doi:10.1159\/000338295http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22710370","DOI":"10.1159\/000338295"},{"key":"bibr4-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Carabotti M, Lahner E, Esposito G, Upper gastrointestinal symptoms in autoimmune gastritis: a cross-sectional study. Medicine 2017;96:e5784:1. doi:10.1097\/MD.0000000000005784http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28072728","DOI":"10.1097\/MD.0000000000005784"},{"key":"bibr5-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Maddalo G, Spolverato Y, Rugge M, Gastrin: from pathophysiology to cancer prevention and treatment. Eur J Cancer Prev 2014;23:258\u201363.doi:10.1097\/CEJ.0000000000000008http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24469263","DOI":"10.1097\/CEJ.0000000000000008"},{"key":"bibr6-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Ferrand A, Wang TC. Gastrin and cancer: a review. Cancer Lett 2006;238:15\u201329.doi:10.1016\/j.canlet.2005.06.025http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16054292","DOI":"10.1016\/j.canlet.2005.06.025"},{"key":"bibr7-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Seva C, Dickinson CJ, Yamada T. Growth-Promoting effects of glycine-extended progastrin. Science 1994;265:410\u20132.doi:10.1126\/science.8023165http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8023165","DOI":"10.1126\/science.8023165"},{"key":"bibr8-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Todisco A, Ramamoorthy S, Witham T, Molecular mechanisms for the antiapoptotic action of gastrin. Am J Physiol Gastrointest Liver Physiol 2001;280:G298\u2013307.doi:10.1152\/ajpgi.2001.280.2.G298http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11208554","DOI":"10.1152\/ajpgi.2001.280.2.G298"},{"key":"bibr9-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Hansen OH, Pedersen T, Larsen JK, Effect of gastrin on gastric mucosal cell proliferation in man. Gut 1976;17:536\u201341.doi:10.1136\/gut.17.7.536http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/964686","DOI":"10.1136\/gut.17.7.536"},{"key":"bibr10-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Smith JP, Solomon TE. Effects of gastrin, proglumide, and somatostatin on growth of human colon cancer. Gastroenterology 1988;95:1541\u20138.doi:10.1016\/S0016-5085(88)80075-1http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2903111","DOI":"10.1016\/S0016-5085(88)80075-1"},{"key":"bibr11-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Kusyk CJ, McNiel NO, Johnson LR. Stimulation of growth of a colon cancer cell line by gastrin. Am J Physiol 1986;251:G597\u2013601.doi:10.1152\/ajpgi.1986.251.5.G597http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3777167","DOI":"10.1152\/ajpgi.1986.251.5.G597"},{"key":"bibr12-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Watson SA, Durrant LG, Crosbie JD, The in vitro growth response of primary human colorectal and gastric cancer cells to gastrin. Int J Cancer 1989;43:692\u20136.doi:10.1002\/ijc.2910430425http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2703274","DOI":"10.1002\/ijc.2910430425"},{"key":"bibr13-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Imdahl A, Eggstein S, Crone C, Growth of colorectal carcinoma cells: regulation in vitro by gastrin, pentagastrin and the gastrin-receptor antagonist proglumide. J Cancer Res Clin Oncol 1989;115:388\u201392.doi:10.1007\/BF00400968http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2760104","DOI":"10.1007\/BF00400968"},{"key":"bibr14-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Sirinek KR, Levine BA, Moyer MP. Pentagastrin stimulates in vitro growth of normal and malignant human colon epithelial cells. Am J Surg 1985;149:35\u20139.doi:10.1016\/S0002-9610(85)80006-4http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3966639","DOI":"10.1016\/S0002-9610(85)80006-4"},{"key":"bibr15-jim-2021-001911","first-page":"302","volume":"99","author":"Winsett OE","year":"1986","journal-title":"Surgery"},{"key":"bibr16-jim-2021-001911","first-page":"4276","volume":"44","author":"Sumiyoshi H","year":"1984","journal-title":"Cancer Res"},{"key":"bibr17-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Smith AM, Watson SA. Gastrin and gastrin receptor activation: an early event in the adenoma-carcinoma sequence. Gut 2000;47:820\u20134.doi:10.1136\/gut.47.6.820http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11076881","DOI":"10.1136\/gut.47.6.820"},{"key":"bibr18-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"De Block CEM, De Leeuw IH, Van Gaal LF. Autoimmune gastritis in type 1 diabetes: a clinically oriented review. J Clin Endocrinol Metab 2008;93:363\u201371.doi:10.1210\/jc.2007-2134http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18029461","DOI":"10.1210\/jc.2007-2134"},{"key":"bibr19-jim-2021-001911","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.06.001"},{"key":"bibr20-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Dixon MF, Genta RM, Yardley JH, Classification and grading of gastritis. The updated Sydney system. International workshop on the histopathology of gastritis, Houston 1994. Am J Surg Pathol 1996;20:1161\u201381.doi:10.1097\/00000478-199610000-00001http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8827022","DOI":"10.1097\/00000478-199610000-00001"},{"key":"bibr21-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Snow CF. Laboratory diagnosis of vitamin B\n                      12\n                      and folate deficiency: a guide for the primary care physician. Arch Intern Med 1999;159:1289\u201398.doi:10.1001\/archinte.159.12.1289http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10386505","DOI":"10.1001\/archinte.159.12.1289"},{"key":"bibr22-jim-2021-001911","first-page":"979","volume":"67","author":"Oh R","year":"2003","journal-title":"Am Fam Physician"},{"key":"bibr23-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Talley NJ, Chute CG, Larson DE, Risk for colorectal adenocarcinoma in pernicious anemia. A population-based cohort study. Ann Intern Med 1989;111:738\u201342.doi:10.7326\/0003-4819-111-9-738http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/2802432","DOI":"10.7326\/0003-4819-111-9-738"},{"key":"bibr24-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Borch K, Renvall H, Liedberg G, Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 1986;21:357\u201363.doi:10.3109\/00365528609003087http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/3715400","DOI":"10.3109\/00365528609003087"},{"key":"bibr25-jim-2021-001911","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2036.2000.00842.x"},{"key":"bibr26-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Renga M, Brandi G, Paganelli GM, Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut 1997;41:330\u20132.doi:10.1136\/gut.41.3.330http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9378387","DOI":"10.1136\/gut.41.3.330"},{"key":"bibr27-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Lahner E, Sbrozzi-Vanni A, Vannella L, No higher risk for colorectal cancer in atrophic gastritis-related hypergastrinemia. Dig Liver Dis 2012;44:793\u20137.doi:10.1016\/j.dld.2012.04.012http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22595617","DOI":"10.1016\/j.dld.2012.04.012"},{"key":"bibr28-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Boursi B, Mamtani R, Haynes K, Pernicious anemia and colorectal cancer risk - A nested case-control study. Dig Liver Dis 2016;48:1386\u201390.doi:10.1016\/j.dld.2016.07.011http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27481584","DOI":"10.1016\/j.dld.2016.07.011"},{"key":"bibr29-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Ciccotosto GD, McLeish A, Hardy KJ, Expression, processing, and secretion of gastrin in patients with colorectal carcinoma. Gastroenterology 1995;109:1142\u201353.doi:10.1016\/0016-5085(95)90572-3http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7557079","DOI":"10.1016\/0016-5085(95)90572-3"},{"key":"bibr30-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Machida-Montani A, Sasazuki S, Inoue M, Atrophic gastritis, Helicobacter pylori, and colorectal cancer risk: a case-control study. Helicobacter 2007;12:328\u201332.doi:10.1111\/j.1523-5378.2007.00513.xhttp:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17669106","DOI":"10.1111\/j.1523-5378.2007.00513.x"},{"key":"bibr31-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Lee JY, Park HW, Choi JY, Helicobacter pylori Infection with Atrophic Gastritis Is an Independent Risk Factor for Advanced Colonic Neoplasm. Gut Liver 2016;10:902\u20139.doi:10.5009\/gnl15340http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27458180","DOI":"10.5009\/gnl15340"},{"key":"bibr32-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Kalkan \u00c7a\u011fda\u015f, Karakaya F, Soykan \u0130rfan, Kalkan C, Soykan I. Factors associated with elevated serum chromogranin A levels in patients with autoimmune gastritis. Turk J Gastroenterol 2016;27:515\u201320.doi:10.5152\/tjg.2016.16486http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27852542","DOI":"10.5152\/tjg.2016.16486"},{"key":"bibr33-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Kleveland O, Syversen U, Sl\u00f8rdahl K, Hypergastrinemia as a cause of chromogranin A increase in blood in patients suspected to have neuroendocrine tumor. Digestion 2001;64:71\u20134.doi:10.1159\/000048842http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11684818","DOI":"10.1159\/000048842"},{"key":"bibr34-jim-2021-001911","doi-asserted-by":"crossref","unstructured":"Sonnenberg A, Genta RM. Helicobacter pylori is a risk factor for colonic neoplasms. Am J Gastroenterol 2013;108:208\u201315.doi:10.1038\/ajg.2012.407http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/23208272","DOI":"10.1038\/ajg.2012.407"}],"container-title":["Journal of Investigative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2021-001911","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1136\/jim-2021-001911","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1136\/jim-2021-001911","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:37:50Z","timestamp":1777459070000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1136\/jim-2021-001911"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["10.1136\/jim-2021-001911"],"URL":"https:\/\/doi.org\/10.1136\/jim-2021-001911","relation":{},"ISSN":["1081-5589","1708-8267"],"issn-type":[{"value":"1081-5589","type":"print"},{"value":"1708-8267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1]]}}}